Amy W. Schulman, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 43,337 shares at $148.93 ($6.4M) on 2024-05-29, disclosed to the SEC on 2024-05-31.
Scheduled sale ($6.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $148.21 | 10,121 | $1.5M | 23.3% |
| 2 | $148.21 | 10,121 | $1.5M | 23.3% |
| 3 | $148.93 | 11,516 | $1.7M | 26.6% |
| 4 | $148.93 | 11,516 | $1.7M | 26.6% |
| 5 | $149.76 | 63 | $9K | 0.1% |
| Total | $148.59 avg | 43,337 |
| $6.4M |
| 100% |
| Filing → |
| ALNY | SELL | 2024-06-27 | $2.0M | — | Filing → |
| SQZ | BUY | 2021-12-15 | $40K | — | Filing → |
| HCII | BUY | 2021-04-14 | $0 | — | Filing → |